DeVita Resigns As No. 2 At Sloan-Kettering To “Pursue Clinical Research,” Hospital Says
In Brief: Abeloff, Fisher Lead ASCO; Henney Replaces Antman On Govt. Relations; Ultmann Retires
Rosenberg Team May Have Cloned Melanoma Gene
ASCO Entering Prime Of Life
Two activists Are Appointed To Complete NCAB
NCAB Seeks Greater flexibility In Grants Target To Aid P01s
Women’s Health Study To Supplant Need for WHT, Greenwald Says
Nurses Must Assist In Pain Management, ONS Says
Regions Outlined In CIS Proposal
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ
